Scientific perspectives on drug transporters and their role in drug interactions

被引：125
作者：
Zhang, Lei [1 ]
Strong, John M. [1 ]
Qiu, Wei [1 ]
Lesko, Lawrence J. [1 ]
Huang, Shiew-Mei [1 ]
机构：
[1] CIDER Off 1, Ctr Drug Evaluat & Res Food & Drug Adm, Off Clin Pharmacol & Biopharmaceut, Silver Spring, MD 20993 USA
来源：
MOLECULAR PHARMACEUTICS | 2006年 / 3卷 / 01期
关键词：
transporter; drug-drug interaction; regulatory; guidance; new drug application; drug development; exposure-response relationship; labeling; risk management;
D O I：
10.1021/mp050095h
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Recently, increased interest in drug transporters and research in this area has revealed that drug transporters play an important role in modulating drug absorption, distribution, and elimination. Acting alone or in concert with drug metabolizing enzymes they can affect the pharmacokinetics and pharmacodynamics of a drug. This commentary will focus on the potential role that drug transporters may play in drug-drug interactions and what information may be needed during drug development and new drug application (NDA) submissions to address potential drug interactions mediated by transporters.
引用
收藏
页码：62 / 69
页数：8
相关论文
共 55 条
  • [1] P-glycoprotein: from genomics to mechanism
    Ambudkar, SV
    Kimchi-Sarfaty, C
    Sauna, ZE
    Gottesman, MM
    [J]. ONCOGENE, 2003, 22 (47) : 7468 - 7485
  • [2] Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests
    Andersson, T
    Flockhart, DA
    Goldstein, DB
    Huang, SM
    Kroetz, DL
    Milos, PM
    Ratain, MJ
    Thummel, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 559 - 581
  • [3] [Anonymous], 2004, ALLEGRA D 24 H LABEL
  • [4] [Anonymous], 2003, EXPOSURE RESPONSE RE
  • [5] Role of transport proteins in drug absorption, distribution and excretion
    Ayrton, A
    Morgan, P
    [J]. XENOBIOTICA, 2001, 31 (8-9) : 469 - 497
  • [6] Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
    Benet, LZ
    Cummins, CL
    Wu, CY
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) : 3 - 9
  • [7] Transporter-enzyme interactions:: Implications for predicting drug-drug interactions from in vitro data
    Benet, LZ
    Cummins, CL
    Wu, CY
    [J]. CURRENT DRUG METABOLISM, 2003, 4 (05) : 393 - 398
  • [8] The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
    Bjornsson, TD
    Callaghan, JT
    Einolf, HJ
    Fischer, V
    Gan, L
    Grimm, S
    Kao, J
    King, SP
    Miwa, G
    Ni, L
    Kumar, G
    McLeod, J
    Obach, SR
    Roberts, S
    Roe, A
    Shah, A
    Snikeris, F
    Sullivan, JT
    Tweedie, D
    Vega, JM
    Walsh, J
    Wrighton, SA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (05) : 443 - 469
  • [9] Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
    Boyd, RA
    Stern, RH
    Stewart, BH
    Wu, XC
    Reyner, EL
    Zegarac, EA
    Randinitis, EJ
    Whitfield, L
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01) : 91 - 98
  • [10] CEPHALOSPORIN-PROBENECID DRUG-INTERACTIONS
    BROWN, GR
    [J]. CLINICAL PHARMACOKINETICS, 1993, 24 (04) : 289 - 300
123456